Quadrant Capital Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,859
Closed -$38.6K 2363
2025
Q1
$38.6K Buy
4,859
+2,840
+141% +$20.8K ﹤0.01% 1803
2024
Q4
$11K Buy
2,019
+899
+80% +$5.5K ﹤0.01% 2096
2024
Q3
$8.09K Buy
1,120
+784
+233% +$7.18K ﹤0.01% 2203
2024
Q2
$3.65K Buy
+336
New +$4.3K ﹤0.01% 2371
2023
Q4
Sell
-689
Closed -$14.2K 2769
2023
Q3
$14.2K Buy
689
+647
+1,540% +$18.7K ﹤0.01% 1852
2023
Q2
$1.98K Sell
42
-20
-32% -$995 ﹤0.01% 2420
2023
Q1
$2.6K Buy
62
+20
+48% +$860 ﹤0.01% 2379
2022
Q4
$1.6K Sell
42
-25
-37% -$955 ﹤0.01% 2469
2022
Q3
$3K Hold
67
﹤0.01% 2296
2022
Q2
$2K Buy
67
+42
+168% +$1.41K ﹤0.01% 2271
2022
Q1
$1K Sell
25
-34
-58% -$1.28K ﹤0.01% 2377
2021
Q4
$3K Buy
59
+31
+111% +$1.3K ﹤0.01% 2059
2021
Q3
$1K Sell
28
-32
-53% -$1.47K ﹤0.01% 2380
2021
Q2
$3K Sell
60
-9
-13% -$636 ﹤0.01% 2032
2021
Q1
$5K Sell
69
-12
-15% -$984 ﹤0.01% 1802
2020
Q4
$7K Buy
81
+15
+23% +$1.11K ﹤0.01% 1589
2020
Q3
$4K Buy
66
+41
+164% +$2.08K ﹤0.01% 1652
2020
Q2
$1K Sell
25
-85
-77% -$3.08K ﹤0.01% 2118
2020
Q1
$3K Buy
110
+103
+1,471% +$5.96K ﹤0.01% 1808
2019
Q4
$0 Sell
7
-169
-96% -$20.8K ﹤0.01% 2479
2019
Q3
$23K Sell
176
-172
-49% -$28.8K ﹤0.01% 1554
2019
Q2
$62K Hold
348
0.01% 1115
2019
Q1
$53K Buy
348
+341
+4,871% +$49.4K 0.01% 1191
2018
Q4
$0 Buy
+7
New +$801 ﹤0.01% 2279

Other funds holding SAGE